Key facts
- This page summarizes Eric K. Rowinsky's Form 4 filing for BIOGEN INC. (BIIB).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 17 Jun 2022, 17:14.
Eric K. Rowinsky - 15 Jun 2022 Form 4 Insider Report for BIOGEN INC. (BIIB)
- Role
- Director
- Signature
- /s/ Wendell Taylor, Attorney in Fact for Eric K. Rowinsky
- Issuer symbol
- BIIB
- Transactions as of
- 15 Jun 2022
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 17 Jun 2022, 17:14:45 UTC
- Previous filing
- 20 Dec 2022
- Next filing
- 24 Jun 2022
- SEC
- View on sec.gov
Key filing fact
Eric K. Rowinsky filed Form 4 for BIOGEN INC. (BIIB) on 17 Jun 2022.
Change
- Previous filing in this sequence was filed on 20 Dec 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
BIIB
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +1,370
- Change %
- +7.7%
- Price
- $0.000000
- Shares after
- 19,214
- Date
- 15 Jun 2022
- Ownership
- Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.